Literature DB >> 21960113

A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema.

Sheila H Ridner1, Barbara Murphy, Jie Deng, Nancy Kidd, Emily Galford, Candace Bonner, Stewart M Bond, Mary S Dietrich.   

Abstract

Treatment of the truncal lymphatics prior to treatment of the lymphedematous arm is an accepted, although not empirically tested, therapeutic intervention delivered during decongestive lymphatic therapy (DLT). Breast cancer survivors with arm lymphedema are encouraged to use these techniques when performing simple lymphatic drainage as part of their life-long lymphedema self-care. Self-massage is at times difficult and pneumatic compression devices are used by many patients to assist with self-care. One such device, the Flexitouch(®) System, replicates the techniques used during DLT; however, the need for application of pneumatic compression in unaffected truncal areas to improve self-care outcomes in arm only lymphedema is not established. The objective of this study was to compare the therapeutic benefit of truncal/chest/arm advanced pneumatic compression therapy (experimental group) verses arm only pneumatic compression (control group) in self-care for arm lymphedema without truncal involvement using the Flexitouch(®) System. Outcomes of interest were self-reported symptoms, function, arm impedance ratios, circumference, volume, and trunk circumference. Forty-two breast cancer survivors, (21 per group), with Stage II lymphedema completed 30 days of home self-care using the Flexitouch(®) System. Findings revealed a statistically significant reduction in both the number of symptoms and overall symptom burden within each group; however, there were no statistically significant differences in these outcomes between the groups. There was no statistically significant overall change or differential pattern of change between the groups in function. A statistically significant reduction in bioelectrical impedance and arm circumference within both of the groups was achieved; however, there was no statistically significant difference in reduction between groups. These findings indicate that both configurations are effective, but that there may be no added benefit to advanced pneumatic treatment of the truncal lymphatics prior to arm massage when the trunk is not also affected. Further research is indicated in a larger sample.

Entities:  

Mesh:

Year:  2011        PMID: 21960113     DOI: 10.1007/s10549-011-1795-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema.

Authors:  Justin C Brown; Andrea L Cheville; Julia C Tchou; Susan R Harris; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2013-09-07       Impact factor: 3.603

Review 2.  Rehabilitation interventions for the management of breast cancer-related lymphedema: developing a patient-centered, evidence-based plan of care throughout survivorship.

Authors:  Kathryn Ryans; Marisa Perdomo; Claire C Davies; Kimberly Levenhagen; Laura Gilchrist
Journal:  J Cancer Surviv       Date:  2021-01-22       Impact factor: 4.442

3.  Development and validation of the Lymphedema Symptom and Intensity Survey-Arm.

Authors:  Sheila H Ridner; Mary S Dietrich
Journal:  Support Care Cancer       Date:  2015-03-10       Impact factor: 3.603

Review 4.  Interventions to promote energy balance and cancer survivorship: priorities for research and care.

Authors:  Catherine M Alfano; Alessio Molfino; Maurizio Muscaritoli
Journal:  Cancer       Date:  2013-06-01       Impact factor: 6.860

5.  Massage interventions and treatment-related side effects of breast cancer: a systematic review and meta-analysis.

Authors:  Yuan Q Pan; Ke H Yang; Yu L Wang; Lai P Zhang; Hai Q Liang
Journal:  Int J Clin Oncol       Date:  2013-11-26       Impact factor: 3.402

6.  Acute Truncal Lymphedema Secondary to Axillary Metastatic Melanoma Presenting Like Cellulitis.

Authors:  Shelley J E Hwang; Benjamin Y Kong; Shaun Chou; Deepal Wakade; Matteo S Carlino; Pablo Fernandez-Penas
Journal:  Case Rep Med       Date:  2017-01-15

7.  Interventions for Breast Cancer-Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA.

Authors:  Claire Davies; Kimberly Levenhagen; Kathryn Ryans; Marisa Perdomo; Laura Gilchrist
Journal:  Phys Ther       Date:  2020-07-19

8.  The Influence of Arm Swelling Duration on Shoulder Pathology in Breast Cancer Patients with Lymphedema.

Authors:  Dae-Hyun Jang; Min-Wook Kim; Se-Jeong Oh; Jae Min Kim
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

9.  Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, an Open-Label Controlled Study.

Authors:  Stanley G Rockson; Pinar Karaca-Mandic; Roman Skoracki; Karen Hock; Michelle Nguyen; Kristin Shadduck; Phyllis Gingerich; Elizabeth Campione; Andrea Leifer; Jane Armer
Journal:  Lymphat Res Biol       Date:  2021-07-02       Impact factor: 2.349

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.